B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Nintedanib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Nintedanib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

su
191 shared targets
kw
203 shared targets
fedratinib
192 shared targets
tae
197 shared targets
tozasertib
161 shared targets
dovitinib
151 shared targets
lestaurtinib
214 shared targets
midostaurin
157 shared targets
r
174 shared targets
pha
134 shared targets
Loading evidence profile...

This evidence profile for Nintedanib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.